# Oxycodone-naloxone in Relieving Opioid-related Constipation

> **NCT00412152** · PHASE3 · COMPLETED · sponsor: **Mundipharma Research GmbH & Co KG**

## Conditions studied

- Pain

## Interventions

- **DRUG:** Oxycodone nalaxone prolonged release tablets (OXN)

## Key facts

- **NCT ID:** NCT00412152
- **Lead sponsor:** Mundipharma Research GmbH & Co KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** — (—)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412152, "Oxycodone-naloxone in Relieving Opioid-related Constipation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00412152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*